Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Oct 2023. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
5274837016 | Product containing only cytarabine and daunorubicin in parenteral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
5274838014 | Cytarabine and daunorubicin only product in parenteral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing only cytarabine and daunorubicin in parenteral dose form (medicinal product form) | Is a | Product containing only cytarabine and daunorubicin (medicinal product) | true | Inferred relationship | Some | ||
Product containing only cytarabine and daunorubicin in parenteral dose form (medicinal product form) | Is a | Product containing cytarabine and daunorubicin in parenteral dose form (medicinal product form) | true | Inferred relationship | Some | ||
Product containing only cytarabine and daunorubicin in parenteral dose form (medicinal product form) | Has manufactured dose form | Parenteral dose form (dose form) | true | Inferred relationship | Some | ||
Product containing only cytarabine and daunorubicin in parenteral dose form (medicinal product form) | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Some | ||
Product containing only cytarabine and daunorubicin in parenteral dose form (medicinal product form) | Has active ingredient | Daunorubicin (substance) | true | Inferred relationship | Some | 1 | |
Product containing only cytarabine and daunorubicin in parenteral dose form (medicinal product form) | Has active ingredient | Cytarabine (substance) | true | Inferred relationship | Some | 2 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Cytarabine 100 mg and daunorubicin 44 mg powder for solution for infusion vial | Is a | True | Product containing only cytarabine and daunorubicin in parenteral dose form (medicinal product form) | Inferred relationship | Some |
This concept is not in any reference sets